G. Schulz

1.9k total citations
42 papers, 1.5k citations indexed

About

G. Schulz is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, G. Schulz has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 17 papers in Oncology and 13 papers in Immunology. Recurrent topics in G. Schulz's work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (13 papers) and Neutropenia and Cancer Infections (11 papers). G. Schulz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (17 papers), Acute Myeloid Leukemia Research (13 papers) and Neutropenia and Cancer Infections (11 papers). G. Schulz collaborates with scholars based in Germany, United States and Austria. G. Schulz's co-authors include Oliver G. Ottmann, R A Reisfeld, Arnold Ganser, F. Herrmann, Jürgen Frisch, D. Hoelzer, David A. Cheresh, John R. Harper, R Mertelsmann and A. Lindemann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

G. Schulz

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Schulz Germany 17 825 567 429 320 227 42 1.5k
CA Juttner Australia 17 1.6k 2.0× 723 1.3× 697 1.6× 363 1.1× 254 1.1× 28 2.2k
MA Moore United States 22 1.1k 1.3× 343 0.6× 704 1.6× 475 1.5× 162 0.7× 31 2.0k
M. Y. Gordon United Kingdom 26 1.3k 1.5× 427 0.8× 346 0.8× 460 1.4× 151 0.7× 78 1.9k
DN Haylock Australia 12 1.5k 1.8× 630 1.1× 562 1.3× 307 1.0× 226 1.0× 20 1.9k
SG Emerson United States 20 1.0k 1.2× 404 0.7× 579 1.3× 424 1.3× 197 0.9× 34 1.8k
JW Adamson United States 21 1.2k 1.5× 291 0.5× 355 0.8× 379 1.2× 149 0.7× 55 1.8k
Bernard Lenormand France 20 355 0.4× 512 0.9× 336 0.8× 211 0.7× 58 0.3× 52 1.6k
Magdalena Czader United States 20 590 0.7× 310 0.5× 239 0.6× 518 1.6× 63 0.3× 76 1.6k
Yen‐Michael S. Hsu United States 13 692 0.8× 487 0.9× 484 1.1× 452 1.4× 90 0.4× 35 1.5k
R.S. Hill United States 11 570 0.7× 185 0.3× 238 0.6× 174 0.5× 110 0.5× 20 822

Countries citing papers authored by G. Schulz

Since Specialization
Citations

This map shows the geographic impact of G. Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Schulz more than expected).

Fields of papers citing papers by G. Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Schulz. The network helps show where G. Schulz may publish in the future.

Co-authorship network of co-authors of G. Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of G. Schulz. A scholar is included among the top collaborators of G. Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Schulz. G. Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weber-Nordt, R, et al.. (1996). Umbilical cord blood: An alternative to the transplantation of bone marrow stem cells. Cancer Treatment Reviews. 22(5). 381–391. 9 indexed citations
2.
Valent, Peter, Klaus Geißler, Michael Andreeff, et al.. (1993). Combination Treatment of Acute Myeloblastic Leukemia with rhGM-CSF and Standard Induction Chemotherapy. Cancer Investigation. 11(2). 229–234. 2 indexed citations
3.
Ganser, Arnold, Oliver G. Ottmann, G. Seipelt, et al.. (1993). Effect of long-term treatment with recombinant human interleukin-3 in patients with myelodysplastic syndromes.. PubMed. 7(5). 696–701. 35 indexed citations
4.
Hess, U, A. Ganser, Schnürch Hg, et al.. (1992). MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE‐MACROPHAGE COLONY‐STIMULATING FACTOR (rhGM‐CSF). British Journal of Haematology. 80(2). 254–256. 25 indexed citations
5.
Ganser, Arnold, A Lindemann, G. Seipelt, et al.. (1991). Recombinant Human Interleukin-3 in Patients with Hematopoietic Failure. Recent results in cancer research. 121. 162–172. 1 indexed citations
6.
Schulz, G., et al.. (1991). New Therapeutic Modalities for the Clinical Use of rhGM-CSF in Patients with Malignancies. American Journal of Clinical Oncology. 14. S19–26. 11 indexed citations
7.
Lindemann, A., Arnold Ganser, F. Herrmann, et al.. (1991). Biologic effects of recombinant human interleukin-3 in vivo.. Journal of Clinical Oncology. 9(12). 2120–2127. 56 indexed citations
8.
Schulz, G.. (1991). Grippers for flexible textiles. 21 indexed citations
9.
Link, H., J. Seidel, Monika Stoll, et al.. (1990). Regeneration of Granulopoiesis with Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor After Bone Marrow Transplantation. Hämatologie und Bluttransfusion. 33. 741–746. 4 indexed citations
10.
Herrmann, F., G. Schulz, Karin Kolbe, et al.. (1990). Effect of Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Related Morbidity Induced by Myelotoxic Chemotherapy. Hämatologie und Bluttransfusion. 33. 717–723. 12 indexed citations
11.
Ottmann, Oliver G., et al.. (1990). Effects of recombinant human interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood. 76(4). 666–676. 196 indexed citations
12.
Herrmann, F., Arnold Ganser, A Lindemann, et al.. (1990). Stimulation of granulopoiesis in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor: assessment of two routes of administration.. PubMed. 9(5). 475–9. 7 indexed citations
13.
Ganser, Arnold, Oliver G. Ottmann, G. Schulz, & D. Hoelzer. (1989). Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor and Low-Dose Cytosine Arabinoside in Patients with Myelodysplastic Syndrome. Oncology Research and Treatment. 12(1). 13–15. 15 indexed citations
14.
Herrmann, François R., G. Schulz, A Lindemann, et al.. (1989). Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor.. Journal of Clinical Oncology. 7(2). 159–167. 151 indexed citations
15.
Herrmann, F., A. Lindemann, H Klein, et al.. (1989). Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.. PubMed. 3(5). 335–8. 78 indexed citations
16.
Bosslet, Klaus, et al.. (1988). Immunological tailoring of monoclonal antibodies for immunotherapy of pancreatic carcinoma. International Journal of Cancer. 41(S2). 85–88. 4 indexed citations
17.
Beelen, Dietrich W., Ullrich Graeven, G. Schulz, et al.. (1988). Treatment of Acute Graft-Versus-Host Disease After HLA-Partially Matched Marrow Transplantation with a Monoclonal Antibody (BMA031) Against the T Cell Receptor. Oncology Research and Treatment. 11(1). 56–58. 7 indexed citations
18.
Bosslet, Klaus, et al.. (1988). [Immunoscintigraphy of colorectal cancers and specific immunotherapy of pancreatic cancers using monoclonal antibodies].. PubMed. 138(11-12). 255–7. 1 indexed citations
19.
Schulz, G., Markus W. Büchler, R Klapdor, et al.. (1988). Immunotherapy of pancreatic cancer with monoclonal antibody BW 494. International Journal of Cancer. 41(S2). 89–94. 13 indexed citations
20.
Schulz, G., et al.. (1985). Eradication of established human melanoma tumors in nude mice by antibody-directed effector cells.. The Journal of Experimental Medicine. 161(6). 1315–1325. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CA Juttner Breakdown of academic impact, for papers by MA Moore Breakdown of academic impact, for papers by M. Y. Gordon Breakdown of academic impact, for papers by DN Haylock Breakdown of academic impact, for papers by SG Emerson Breakdown of academic impact, for papers by JW Adamson Breakdown of academic impact, for papers by Bernard Lenormand Breakdown of academic impact, for papers by Magdalena Czader Breakdown of academic impact, for papers by Yen‐Michael S. Hsu Breakdown of academic impact, for papers by R.S. Hill
Rankless by CCL
2026